Assess whether the AI buy is high-risk and under-evaluated (f17818)

Situation

After a second-request-style exam letter on model risk, Medicare billing-pattern outlier table is what federal AI-procurement reviewer can touch in an agency buying an AI system for benefits decisions. US Federal will live with Pursue versus Pursue with conditions on this M&A Regulatory Due Diligence file.

Decision

Federal AI-procurement reviewer in an agency buying an AI system for benefits decisions must choose Pursue / Pursue with conditions / Partner / No-bid using Medicare billing-pattern outlier table after a second-request-style exam letter on model risk.

Hypotheses to test

• Authorize Pursue now; Medicare billing-pattern outlier table already has the discriminator after a second-request-style exam letter on model risk.
• Keep Pursue with conditions in force until Medicare billing-pattern outlier table is completed after a second-request-style exam letter on model risk for federal AI-procurement reviewer.
• Treat Medicare billing-pattern outlier table as Partner because both readings appear after a second-request-style exam letter on model risk.
• Refuse a US Federal close: federal AI-procurement reviewer does not have the page the AI buy is turns on in Medicare billing-pattern outlier table.

Analysis required

• Map FAR, Section L/M, and evaluator priorities in Medicare billing-pattern outlier table after a second-request-style exam letter on model risk.
• Name the evaluation right federal AI-procurement reviewer would forfeit by rushing.
• Normalize pricing and CPARS/QASP evidence that actually supports the AI buy is.
• For this US Federal M&A Regulatory Due Diligence file, read Medicare billing-pattern outlier table against a second-request-style exam letter on model risk and write the one fact that would move the AI buy is for federal AI-procurement reviewer.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / M&A Regulatory Due Diligence packet (Medicare billing-pattern outlier table after a second-request-style exam letter on model risk). The follow-on M&A Regulatory Due Diligence action is what federal AI-procurement reviewer does next: implement the option, assign an owner, and log the missing fact.